If you’ve been researching fertility after 35, you’ve likely come across the term AMH — anti-Müllerian hormone. It’s one of the most discussed markers in conversations about ovarian reserve, yet it’s also one of the most misunderstood. Understanding what AMH actually measures, and what the research says about it, can help provide meaningful context as you navigate your reproductive health journey.
AMH is produced by the small follicles in your ovaries and is considered a reliable indicator of ovarian reserve — the approximate number of eggs remaining. Levels naturally decline with age, but the pace and degree of that decline varies considerably from person to person. For women over 35, AMH testing has become a common part of fertility evaluations, though interpreting the results requires nuance and professional guidance.
It’s worth noting from the outset that AMH is one piece of a broader picture. A single number doesn’t determine your fertility outcomes, and many women with lower AMH levels conceive naturally or with assistance. Understanding the full context of what this marker means — and doesn’t mean — is an important starting point.
What Research Shows About AMH and Ovarian Reserve
According to research published through the National Institutes of Health, AMH levels begin to decline gradually from a woman’s mid-20s, with a more noticeable decrease typically occurring after age 35. By the early 40s, many women have significantly lower levels than they did in their 30s, though individual variation is substantial.
Studies suggest that AMH correlates reasonably well with the number of antral follicles — small follicles that can potentially develop into mature eggs. However, research also indicates that AMH is a better predictor of ovarian response to stimulation (as used in IVF) than it is of natural conception rates. This distinction matters significantly when interpreting your own results.
A 2017 study found that among women trying to conceive naturally, AMH levels were not strongly associated with the probability of conception within a given cycle, suggesting that other factors — including egg quality, sperm health, uterine environment, and timing — play important roles alongside ovarian reserve.
Understanding AMH Reference Ranges After 35
AMH levels are measured in ng/mL or pmol/L, depending on the laboratory. Reference ranges vary between labs and should always be interpreted in the context of your age and clinical picture. What’s considered “normal” for a 38-year-old differs from what’s expected at 32 or 42.
Generally speaking, levels that fall within age-appropriate ranges suggest adequate ovarian reserve for your age. Lower-than-expected levels may indicate diminished ovarian reserve, while higher levels can sometimes be associated with conditions like polycystic ovary syndrome (PCOS). A reproductive endocrinologist or OB/GYN is best positioned to interpret your specific results alongside other assessments.
When a Low AMH Result Doesn’t Tell the Full Story
One of the most important things research suggests is that AMH captures quantity, not quality. Egg quality — which is influenced by different factors and declines on its own timeline — is not reflected in AMH numbers. A woman can have a lower AMH and still have good-quality eggs, just as a woman with higher AMH may face quality-related challenges. This is one reason why AMH is considered most useful as part of a comprehensive fertility workup rather than a standalone test.
How AMH Fits Into a Fertility Evaluation
For women over 35 considering a fertility evaluation, AMH is typically one of several assessments. A complete picture usually includes an antral follicle count (AFC) via ultrasound, FSH and estradiol levels measured on cycle day 2 or 3, and a thorough review of menstrual history and overall health. Together, these provide a more comprehensive picture of ovarian reserve and reproductive health than any single test alone.
If your AMH comes back lower than expected, it may prompt conversations about timing, assisted reproductive options, or simply closer monitoring. It doesn’t automatically indicate infertility. Many women with low AMH conceive with or without medical assistance, and understanding your complete profile with a specialist can help clarify what the number means for your individual situation.
AMH Testing: Practical Considerations
AMH levels are relatively stable across the menstrual cycle, which means testing can typically be done at any point — unlike FSH, which must be measured on specific cycle days. However, some factors may influence results, including hormonal contraceptives (which may suppress AMH levels), recent illness, and certain medications.
If you’re considering AMH testing, discussing the timing and context with your healthcare provider can help ensure the results are as accurate and interpretable as possible. It’s also worth asking about what additional tests might provide a more complete assessment of your reproductive health.
Frequently Asked Questions
Can AMH levels change over time?
AMH levels naturally decline with age and generally cannot be increased through lifestyle interventions, though some small fluctuations may occur. If you’ve had a low result, retesting in a few months may offer additional context, but a significant reversal is not typically expected. A reproductive endocrinologist can help interpret any changes in the context of your broader health picture.
Does a low AMH mean I can’t get pregnant naturally?
Research indicates that AMH is a better predictor of response to ovarian stimulation than natural conception rates. Many women with lower-than-expected AMH levels conceive naturally. Individual fertility is influenced by many factors, and a single marker doesn’t determine outcomes. Consulting a fertility specialist can help you understand what your results mean for your specific situation.
Is AMH testing recommended for all women over 35?
AMH testing is not universally recommended for all women over 35 — it’s typically most useful for those actively trying to conceive, considering fertility treatments, or seeking information about ovarian reserve before making reproductive decisions. Your OB/GYN or reproductive endocrinologist can help determine whether AMH testing is appropriate for your circumstances.
What should I do if my AMH is lower than expected?
A lower-than-expected AMH result is worth discussing thoroughly with a fertility specialist. Depending on your age, timeline, and other test results, they may recommend monitoring, further evaluation, or a conversation about reproductive options. It’s an important data point — but one piece of a broader conversation about your fertility health.
Key Takeaways
- AMH reflects ovarian reserve (egg quantity) but not egg quality, and should be interpreted alongside other fertility markers.
- Research suggests AMH is more predictive of IVF response than natural conception rates, meaning a lower result doesn’t preclude natural conception.
- Levels naturally decline with age, but individual variation is considerable — what matters most is the context provided by a comprehensive evaluation.
- AMH testing is most useful when interpreted by a healthcare provider alongside other assessments, including antral follicle count and hormone levels.
- If you have questions about your AMH results, a reproductive endocrinologist is the most appropriate specialist to consult.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.
Research Context and Professional Guidance
According to the Centers for Disease Control and Prevention, evidence around fertility and reproductive health after 35 underscores the importance of individual variation — population-level findings provide useful context without predicting any one person’s experience. The research in this area continues to evolve, and evidence-based guidance from a qualified healthcare provider remains the most reliable resource for personal health decisions.
For women navigating these transitions, consulting a healthcare provider familiar with midlife women’s health — whether a general practitioner, OB/GYN, or relevant specialist — can help ensure that individual factors are appropriately assessed. If symptoms or concerns are affecting daily functioning or quality of life, that is a reasonable threshold for seeking professional input rather than managing alone.